For instance, [64Cu]Cu-CB-TE2A-F(ab’)2-mAb105 was used by Wehrenberg-Klee et al. to monitor cellular changes under AKT and PI3K inhibitors, demonstrating a significant relationship between tumor uptake and increased HER3 levels after therapy. The gene discussed is ERBB3; the disease is neoplasm.